Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
HOME > COLUMN
COLUMN
-
New York Note - 2: The Tariff Roller Coaster
November 5, 2026
-
Japan’s Healthcare Pulse: An 18-Month Market Snapshot
October 30, 2026
-
New York Note - 1: JETRO’s Role in Connecting Japan with the World
October 23, 2026
-
Outside the Bubble: Lunch with Pharma Delegates
September 30, 2026
-
The One Mistake on Your Resume
August 31, 2026
-
Why Your Brain Wants You to Stay (Even When You Want to Go)
July 31, 2026
-
The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard
June 26, 2026
-
More Positions, More Candidates: A Snapshot of Movement in Japan’s Pharma Industry
May 29, 2026
-
The Patient North Star: How Gilead Japan Redefined Innovation
April 8, 2026
-
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
March 27, 2026
-
The Strategic MSL: Beyond Data Delivery, It’s About Impact
February 19, 2026
-
AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential
January 27, 2026
-
AI: Your New HR BFF (Not Your Replacement!)
December 24, 2025
-
AI in HR: Navigating the Ethical Minefield
November 28, 2025
-
The Unseen Edge & the Shadow of Bias: Awareness as the Cornerstone of Leadership Success
October 31, 2025
-
The Keen Eye: Awareness as a Leadership Cornerstone
September 29, 2025
-
A “50-Billion-Yen Plus” Newcomer
September 4, 2025
-
AI in Japanese Pharma: Now, Not Later!
August 29, 2025
-
Beyond the Bench: Why Biopharma Needs Strategic Thinkers
July 28, 2025
-
AI Is Redefining Healthcare: Insights from Prospection Japan’s Conference
June 27, 2025
